Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences
Olivier Gires1, Nikolas H Stoecklein
1Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University of Munich, Marchioninistr. 15, 81377, Munich, Germany, olivier.gires@med.uni-muenchen.de.
Detecting circulating tumor cells (CTCs) is crucial for cancer metastasis. This review explores why the epithelial marker EpCAM expression changes, impacting CTC detection during cancer progression.
Area of Science:
- Oncology
- Cancer Biology
- Cellular Biology
Background:
- Metastasis formation is a critical and lethal aspect of cancer progression.
- Circulating and disseminated tumor cells (CTCs/DTCs) are key drivers of metastasis.
- Accurate detection and characterization of CTCs/DTCs are vital for cancer research and treatment.
Purpose of the Study:
- To review the dynamic expression of EpCAM in carcinoma cells.
- To summarize potential mechanisms and reasons for EpCAM expression changes.
- To highlight the implications of EpCAM dynamics for CTC/DTC detection strategies.
Main Methods:
- Literature review of studies investigating EpCAM expression in cancer cells.
- Analysis of data on epithelial-to-mesenchymal transition (EMT) and EpCAM regulation.
- Synthesis of current understanding regarding EpCAM's role in metastasis.
Main Results:
- EpCAM expression is not static and can be dynamically regulated in carcinoma cells.
- Loss of EpCAM expression is frequently observed during epithelial-to-mesenchymal transition (EMT).
- Dynamic EpCAM expression poses challenges for current CTC/DTC detection methods relying on EpCAM capture.
Conclusions:
- Understanding the dynamic regulation of EpCAM is essential for improving CTC/DTC detection.
- Alternative or complementary markers may be needed to overcome EpCAM expression variability.
- Further research into EpCAM modulation during cancer progression is warranted for enhanced diagnostic and prognostic tools.
More Related Videos
05:17Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
